Prevent Cancer Foundation welcomes largest-ever Corporate Membership Program cohort in 2026
即时发布
凯拉·梅斯特
703-836-1746
kyra.meister@preventcancer.org
Alexandria, Va. – The Prevent Cancer Foundation® is proud to welcome 23 leading companies to its Corporate Membership Program. Together, they make up the program’s largest-ever cohort, strengthening a growing network of business leaders dedicated to reducing the impact of cancer through prevention and early detection.
Program members receive exclusive access to Foundation events and resources while providing vital support for the Foundation’s work in education, outreach, advocacy and community. Through collaboration and the exchange of ideas, members help advance cancer prevention and early detection efforts, empowering people to take steps that can improve health outcomes and save more lives.
“Our corporate partners play a vital role in advancing cancer prevention and early detection nationwide,” said Jody Hoyos, CEO of the Prevent Cancer Foundation. “We’re proud to work alongside companies that share our vision of a world where cancer is preventable, detectable and beatable for all.”
The 2026 class of corporate members, as of the date of this publication, include:
Silver members
- Abbott
- 百时美施贵宝
- Hologic
- 辉瑞
- 美国药物研究与制造商协会
Bronze members
- AbbVie
- Astellas
- AstraZeneca
- Boehringer Ingelheim
- 卫材
- Eli Lilly & Co
- Exelixis
- 自由
- 基因泰克
- Geneoscopy
- GSK
- Guardant Health
- 默克
- Mercy BioAnalytics
- Natera
- 诺华
- Sanofi
The Corporate Membership Program is open to companies who support the Foundation’s mission: Stopping Cancer. Saving Lives. To learn more or inquire about joining, contact Anne Potter, Senior Director of Corporate and Foundation Relations, at anne.potter@prevencancer.org.
###
关于预防癌症基金会®
预防癌症基金会® is the only U.S.-based nonprofit organization solely dedicated to cancer prevention and early detection. Through research, education, advocacy and community, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated. We are driven by a vision of a world where cancer is preventable, detectable and beatable for all.
基金会正奋起应对到 2035 年将癌症死亡人数减少 40% 的挑战。为实现这一目标,我们承诺投资 $2000 万美元用于创新技术,以早期发现癌症并推进多癌筛查,投资 $1000 万美元用于扩大医疗服务不足社区的癌症筛查和疫苗接种机会,并投资 $1000 万美元用于教育公众有关筛查和疫苗接种的选择。
如需了解更多信息,请访问 www.preventcancer.org.